A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia

British Journal of Haematology

Volumn 163, Issue 1, 2013, Pages 118-122

  Maung, Su W ^a,b   Leahy, Maeve ^a   O'Leary, Hilary M ^a   Khan, Irfan ^c   Cahill, Mary R ^c   Gilligan, Oonagh ^c   Murphy, Philip ^d   Mcpherson, Suzanne ^e   Jackson, Fred ^e   Ryan, Mary ^e   Hennessy, Brian ^e   Mchugh, Johnny ^b   Goodyer, Matthew ^f   Bacon, Larry ^f   O'Gorman, Peter ^f   Nee, Aisling ^g   O'Dwyer, Michael ^g   Enright, Helen ^b   Saunders, Jean ^h   O'Keeffe, Denis ^a  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c Department of Medicine National University of Ireland Cork   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

^e WATERFORD REGIONAL HOSPITAL   (Ireland)

^f MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^g UNIVERSITY HOSPITAL GALWAY   (Ireland)

^h UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Autoimmune haemolytic anaemia; Multicentre; Retrospective; Rituximab; Safety

Indexed keywords

AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; CYCLOSPORIN; HEMOGLOBIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; PREDNISOLONE; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IRELAND; MALE; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SEPSIS; SPLENECTOMY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; WARM AUTOIMMUNE HEMOLYTIC ANEMIA;

AUTOIMMUNE HAEMOLYTIC ANAEMIA; MULTICENTRE; RETROSPECTIVE; RITUXIMAB; SAFETY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IRELAND; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884207995     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12486     Document Type: Article

References (18)

1. Akpek, G., McAneny, D. & Weintraub, L. (1999) Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. American Journal of Hematology, 61, 98-102.
2. Barcellini, W. & Zanella, A. (2011) Rituximab therapy for autoimmune haematological diseases. European Journal of Internal Medicine, 22, 220-229.
3. Barcellini, W., Zaja, F., Zaninioni, A., Imperiali, F.G., Battista, M.L., Di Bona, E., Fattizzo, B., Consonni, D., Cortellezzi, A., Fanin, R. & Zanella, A. (2012) Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood, 119, 3691-3697.
4. Bussone, G., Ribeiro, E., Dechartres, A., Viallard, J.F., Bonnotte, B., Fain, O., Godeau, B. & Michel, M. (2009) Efficacy and safety of rituximab in adults' warm autoimmune haemolytic anemia: retrospective an analysis of 27 cases. American Journal of Hematology, 84, 153-157.
5. Carson, K. R., Evens, A.M., Richey, E.A., Habermann, T.M., Focosi, D., Seymour, J.F., Laubach, J., Bawn, S.D., Gordon, L.I., Winter, J.N., Furman, R.R., Vose, J.M., Zelenetz, A.D., Mamtani, R., Raisch, D.W., Dorshimer, G.W., Rosen, S.T., Muro, K., Gottardi-Littell, N.R., Talley, R.L., Sartor, O., Green, D., Major, E.O. & Bennett, CL.(2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood, 113, 4834-4840
6. Chertkov, G. & Dacie, J.V. (1956) Results of splenectomy in auto-immune haemolytic anaemia. British Journal of Haematology, 2, 237-249.
7. Crowther, M., Tracey Chan, Y.L., Garbett, I.K., Lim, W., Vickers, M.A. & Crowther, M.A. (2011) Evidence based focussed review of the treatment of idiopathic warm immune haemolytic anemia in adults. Blood, 118, 4036-4040.
8. Dierickx, D., Verhoef, G., Van Hoof, A., Mineur, P., Roest, A., Triffet, A., Kentos, A., Pierre, P., Boulet, D., Bries, G., Lê, P.Q., Janssens, A. & Delannoy, A. (2009) Rituximab in auto-immune haemolytic anemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Journal of Internal Medicine, 266, 484-491.
9. Garvey, B. (2008) Rituximab in the treatment of Autoimmune Haematological disorders. British Journal of Haematology, 141, 149-169.
10. Gehrs, B.C. & Friedberg, R.C. (2002) Autoimmune haemolytic anemia. American Journal of Hematology, 69, 258-271.
11. Genty, I., Michel, M., Hermine, O., Schaeffer, A, Godeau, B. & Rochant, H. (2002) Characteristics of autoimmune hemolytiv anemia in adults: retrospective analysis of 83 cases. Revue de Medecine Interne, 23, 901-909.
12. Keystone, E., Fleischmann, R., Emery, P., Furst, D.E., van Vollenhoven, R., Bathon, J., Dougados, M., Baldassare, A., Ferraccioli, G., Chubick, A., Udell, J., Cravets, M.W., Agarwal, S., Cooper, S. & Magrini, F. (2007) Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis and Rheumatism, 56, 3896-3908.
13. Lechner, L. & Jager, U. (2010) How I treat autoimmune haemolytic anemia in adults. Blood, 116, 1831-1838.
14. Medeot, M., Zaja, F., Vianelli, N., Battista, M., Baccarani, M., Patriarca, F., Soldano, F., Isola, M., De Luca, S. & Fanin, R. (2008) Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results. European Journal of Haematology, 81, 165-169.
15. Merril, j., Buyon, J., Furie, R., Latinis, K., Gordon, C., Hsieh, H.J. & Brunetta, P. (2011) Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER). Lupus, 20, 709-716
16. Murphy, S. & LoBuglio, A.F. (1976) Drug therapy of autoimmune haemolytic anemia. Seminars Hematology, 13, 323-334.
17. Patel, V.L., Mahévas, M., Lee, S.Y., Stasi, R., Cunningham-Rundles, S., Godeau, B., Kanter, J., Neufeld, E., Taube, T., Ramenghi, U., Shenoy, S., Ward, M.J., Mihatov, N., Patel, V.L., Bierling, P., Lesser, M., Cooper, N. & Bussel, J.B. (2012) Outcomes five years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood, 119, 5989-5995.
18. Serrano, J. (1992) Review of 200 cases studied in a period of 20 years (1970-1989). Sangre (Barc), 37, 265-274.